Its core features include anti-angiogenesis plus multi-target inhibition, broad-spectrum efficacy in later-line and combination therapies, and controllable administration and safety profile.
Authentic
Guarantee
Fast Delivery
Privacy Anlotinib is an oral small-molecule multi-targeted tyrosine kinase inhibitor, mainly indicated for the treatment of malignant tumors such as non-small···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 82
Anlotinib is an anti-tumor prescription drug primarily indicated for the treatment of specific cancers (e.g., non-small cell lung cancer, soft tissue ···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 75
The specific price of anlotinib is affected by factors such as drug specifications, regions, and medical insurance policies. Currently, no pricing inf···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 81
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



